ATLASATLAS fair value
ATLAS has no fair value for this stock today.
Sejahteraraya Anugrahjaya (SRAJ.JK)
Sejahteraraya Anugrahjaya stock price today, ATLAS forecast and fair value
Healthcare · Medical Care Facilities · Indonesia Stock Exchange · Indonesia
IDR 10,975▼ -0.23%
Prices as of Oct 27, 2026 · IDR
Chance of rising in 1 month
47%
that it ends higher than today in 21 sessions
0%coin flip 50%100%
This is just the summary. See everything on Sejahteraraya Anugrahjaya in ATLAS
ATLAS's own quantitative analysis, all in one place.
- Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
- Officers and shareholdersWho runs the company and which funds hold its shares.
- Customer and supplier mapWho it does business with, from its own filings.
- ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
- AlertsWe let you know when something changes in your stocks.
See everything included
- Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
- NewsThe latest on the company, in one place.
- Crisis simulatorHow your portfolio would do in a crash like 2008.
- Practice risk-free$10,000 in virtual money to invest at real prices.
- Global screenerSearch US stocks and stocks from 47 countries with filters.
On Sejahteraraya Anugrahjaya
- Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
- Officers and shareholdersWho runs the company and which funds hold its shares.
- Customer and supplier mapWho it does business with, from its own filings.
- Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
- NewsThe latest on the company, in one place.
And for you
- ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
- AlertsWe let you know when something changes in your stocks.
- Crisis simulatorHow your portfolio would do in a crash like 2008.
- Practice risk-free$10,000 in virtual money to invest at real prices.
- Global screenerSearch US stocks and stocks from 47 countries with filters.
Plans from €3.99 a month.
ATLAS's model gives Sejahteraraya Anugrahjaya a 47% chance of finishing higher a month from now (21 trading sessions) than today: close to a coin flip.
In half of the simulated outcomes the price ends between IDR 9,571 and IDR 12,212; in 9 out of 10, between IDR 7,712 and IDR 15,156. Estimated annual volatility is 73%.
Price, last 12 months (weekly close)
Key numbers
- Market cap
- IDR 160T
- Market cap (USD)
- $8.9B
- 52-week high
- IDR 19,200
- 52-week low
- IDR 8,525
- Revenue (12 months)
- IDR 2.7T
- Gross margin
- 39.0%
- Operating margin
- -10.7%
- Net margin
- -14.0%
- Beta
- 0.55
What this means
ATLAS does not publish a fair value for SRAJ.JK right now, but it does show its odds of rising: close to a coin flip.
Over the last 52 weeks SRAJ.JK has traded between IDR 8,525 and IDR 19,200. Today it is 42.8% below that high and 29% above its low.
Its beta is 0.55: it tends to move less than the market.
About the company
PT Sejahteraraya Anugrahjaya Tbk provides medical services in Indonesia.
Want to see everything about Sejahteraraya Anugrahjaya?
Get started →Plans from €3.99 a month.
Comparable companies
Other companies in the same line of business:
Frequently asked questions
What does Sejahteraraya Anugrahjaya do?
PT Sejahteraraya Anugrahjaya Tbk provides medical services in Indonesia.
What is the chance SRAJ.JK goes up next month?
47%: close to a coin flip. In half of the simulated outcomes, SRAJ.JK ends the month between IDR 9,571 and IDR 12,212.
How big is Sejahteraraya Anugrahjaya and what is its P/E ratio?
Sejahteraraya Anugrahjaya's market capitalization is IDR 160T. We do not show a P/E because it has no positive earnings to base one on.
How volatile is SRAJ.JK?
ATLAS estimates annual volatility at 73%. In a typical month, half of the outcomes end between IDR 9,571 and IDR 12,212.
Not investment advice. ATLAS estimates are produced by statistical models from public data; they can be wrong and past performance does not predict future results. Consider your own situation before investing. Disclaimer